Glucagon-like peptide-1 receptor agonists and cardiovascular disease: from LEADER to EXSCEL.
Cardiovasc Res · 2018
Last updated 2026-05-28| Journal | Cardiovasc Res, 2018 |
|---|---|
| Citations | 5 |
| Relative citation ratio | 0.17 |
| NIH percentile | 11 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Cardiovascular Risk Reduction |
Full record and abstract on PubMed 30052921 ↗